Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Epigenetics

• Publication date

  2012-09-10

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.4161/epi.22070PMID 22965008PMCID PMC3469458
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Silibinin modulates TNF‐α and IFN‐γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells

  2012cited by this paper
• Epigenetic mechanisms and cancer: An interface between the environment and the genome

  2011cited by this paper
• Epigenetic-Based Therapies in Cancer

  2011cited by this paper
• Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide

  2011cited by this paper
• Combination therapy with vidaza and entinostat suppresses tumor growth and reprograms the epigenome in an orthotopic lung cancer model.

  2011cited by this paper
• Epigenetic control of gene expression in the lung.

  2011cited by this paper
• Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy

  2010cited by this paper
• Silibinin Prevents Lung Tumorigenesis in Wild-Type but not in iNOS−/− Mice: Potential of Real-Time Micro-CT in Lung Cancer Chemoprevention Studies

  2010cited by this paper
• Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers

  2010cited by this paper
• Silibinin inhibits human nonsmall cell lung cancer cell growth through cell‐cycle arrest by modulating expression and function of key cell‐cycle regulators

  2010cited by this paper
• p21Cip1/WAF1 mediates cyclin B1 degradation in response to DNA damage

  2009cited by this paper
• Cytotoxicity Mediated by Histone Deacetylase Inhibitors in Cancer Cells: Mechanisms and Potential Clinical Implications

  2009cited by this paper
• HDAC family: What are the cancer relevant targets?

  2009cited by this paper
• Rational Combinations Using HDAC Inhibitors

  2009influential reference
• Histone deacetylase 3 localizes to the mitotic spindle and is required for kinetochore–microtubule attachment

  2008cited by this paper
• Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter.

  2008cited by this paper
• Silibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cells

  2008cited by this paper
• Lung cancer epigenetics and genetics

  2008cited by this paper
• Histone deacetylase inhibitors in cancer therapy

  2008cited by this paper
• Multitargeted therapy of cancer by silymarin.

  2008cited by this paper
• Histone deacetylase inhibitors in cancer therapy

  2007cited by this paper
• Combinatorial strategies for cancer eradication by silibinin and cytotoxic agents: efficacy and mechanisms

  2007cited by this paper
• Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells

  2007cited by this paper
• Epigenetics: A Landscape Takes Shape

  2007cited by this paper
• p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells

  2007cited by this paper
• Histone deacetylase inhibitors: signalling towards p21cip1/waf1.

  2007cited by this paper
• Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21(WAF1).

  2006cited by this paper
• Histone Deacetylase Inhibitors for Cancer Therapy

  2006cited by this paper
• Anticancer activities of histone deacetylase inhibitors

  2006influential reference
• Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

  2006cited by this paper
• Effect of silibinin on the growth and progression of primary lung tumors in mice.

  2006cited by this paper
• Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies

  2006cited by this paper
• p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.

  2005cited by this paper
• Advances in the biology of lung cancer chemoprevention.

  2005cited by this paper
• From The Cover : Epigenetic differences arise during the lifetime of monozygotic twins

  2005cited by this paper
• Exposure of human lung cancer cells to 8-chloro-adenosine induces G2/M arrest and mitotic catastrophe.

  2004cited by this paper
• Oral Silibinin Inhibits Lung Tumor Growth in Athymic Nude Mice and Forms a Novel Chemocombination with Doxorubicin Targeting Nuclear Factor κB–Mediated Inducible Chemoresistance

  2004cited by this paper
• Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.

  2003cited by this paper
• Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity.

  2002cited by this paper
• Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin.

  2001cited by this paper
• Nuclear Accumulation of p21Cip1 at the Onset of Mitosis: a Role at the G2/M-Phase Transition

  1998cited by this paper
• Partial characterization of the MPM-2 phosphoepitope.

  1997cited by this paper
• Histone acetylation in chromatin structure and transcription

  1997cited by this paper
• Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport

  1991cited by this paper

• Anticancer therapeutic potential of silibinin: current trends, scope and relevance

  2025cites this paper
• Modulating the tumor microenvironment: The role of traditional Chinese medicine in improving lung cancer treatment

  2025cites this paper
• Therapeutic potentials of natural products for post-traumatic stress disorder: A focus on epigenetics

  2024cites this paper
• Molecular Evidence of the Bio-activities of Traditional Home Medicine Ingredients.

  2024cites this paper
• Silibinin, a commonly used therapeutic agent for non‐alcohol fatty liver disease, functions through upregulating intestinal expression of fibroblast growth factor 15/19

  2024cites this paper
• Role of Notch1 Signaling Pathway in Small Cell Lung Carcinoma

  2024cites this paper
• A comprehensive evaluation of the therapeutic potential of silibinin: a ray of hope in cancer treatment

  2024cites this paper
• Nanoplatform to Investigate Tumor-Initiating Cancer Stem Cells: Breaking the Diagnostic Barrier.

  2022cites this paper
• Histone deacetylases modulate resistance to the therapy in lung cancer

  2022cites this paper
• Salvianolic acid B acts against non-small cell lung cancer A549 cells via inactivation of the MAPK and Smad2/3 signaling pathways

  2022cites this paper
• Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions

  2022cites this paper
• Remodeling the Epigenetic Landscape of Cancer—Application Potential of Flavonoids in the Prevention and Treatment of Cancer

  2021cites this paper
• SİLİMARİN, SLIT2 PROTEİNİNİ AKTİVE EDEREK VE CXCR4 EKSPRESYONUNU BASKILAYARAK A549 HÜCRELERİNİ İNHİBE ETTİ

  2021cites this paper
• Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer

  2021cites this paper
• YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation

  2021cites this paper
• Lung Cancer Management with Silibinin: A Historical and Translational Perspective

  2021cites this paper
• Structure and cytotoxicity of trichothecenes produced by the potato-associated fungus Trichothecium crotocinigenum.

  2021cites this paper
• Integrated Analysis of lncRNAs and mRNAs Identifies a Potential Driver lncRNA FENDRR in Lung Cancer in Xuanwei, China

  2020cites this paper
• Anti-cancer Effects of Silibinin: The Current Status in Cancer Chemoprevention

  2020cites this paper
• Epigenetic drug development for autoimmune and inflammatory diseases

  2020cites this paper
• Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance.

  2020cites this paper
• CANCER EPIGENETICS AND THE ROLE OF DIETARY ELEMENTS

  2020cites this paper
• Silibinin Triggers the Mitochondrial Pathway of Apoptosis in Human Oral Squamous Carcinoma Cells

  2020cites this paper
• Targeting epigenetics in cancer: therapeutic potential of flavonoids

  2020cites this paper
• Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science

  2019cites this paper
• Epigenetic Regulation of p21cip1/waf1 in Human Cancer

  2019cites this paper
• MicroRNA-718 serves a tumor-suppressive role in non-small cell lung cancer by directly targeting CCNB1

  2019cites this paper
• Anticancer Attributes of Silibinin: Chemo- and Radiosensitization of Cancer

  2018cites this paper
• PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer

  2017cites this paper
• Epigenetics in lung cancer: What do DNA-methyltransferases do?

  2017cites this paper
• Correlation between histone acetylation and expression of Notch1 in human lung carcinoma and its possible role in combined small-cell lung carcinoma.

  2017cites this paper
• Targeting STAT3 with silibinin to improve cancer therapeutics.

  2017cites this paper
• Nephrotoxicity of epigenetic inhibitors used for the treatment of cancer.

  2016cites this paper
• Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer - A comprehensive review.

  2016cites this paper
• A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma

  2016cites this paper
• Silibinin in cancer therapy : A promising prospect

  2016cites this paper
• Epigenetic therapy in lung cancer and mesothelioma

  2015cites this paper
• Novel functions of USP36 : regulation of histone 2B and the P53-MDM2 pathway through deubiquitination

  2015cites this paper
• Restoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells.

  2015cites this paper
• Combination of HDAC inhibitor TSA and silibinin induces cell cycle arrest and apoptosis by targeting survivin and cyclinB1/Cdk1 in pancreatic cancer cells.

  2015cites this paper
• Silibilin-induces apoptosis in breast cancer cells by modulating p53, p21, Bak and Bcl-XL pathways.

  2015influential citation
• HDAC Inhibitors: A New Radiosensitizer for Non-small-cell Lung Cancer

  2015cites this paper
• Epigenetic activities of flavonoids in the prevention and treatment of cancer

  2015cites this paper
• Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe

  2014cites this paper
• Epigenetic regulation of the neural transcriptome and alcohol interference during development

  2014cites this paper
• Silymarin induces cell cycle arrest and apoptosis in ovarian cancer cells.

  2014cites this paper
• Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma

  2014cites this paper
• Silibinin inhibits proliferation, induces apoptosis and causes cell cycle arrest in human gastric cancer MGC803 cells via STAT3 pathway inhibition.

  2014cites this paper
• A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression

  2014cites this paper
• Epigenetic and disease targets by polyphenols.

  2013cites this paper
• Epigenetic effects of the natural flavonolignan silibinin on colon adenocarcinoma cells and their derived metastatic cells

  2013influential citation
• Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells.

  2013cites this paper
• Epithelial membrane protein 3 is frequently shown as promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.

  2013cites this paper
• Chemopreventive and Anti-Cancer Efficacy of Silibinin Against Growth and Progression of Lung Cancer

  2013cites this paper
• HATs与HDACs在肺癌上皮细胞间质转化中作用机制及其应用的研究进展

  2013cites this paper
• Silibinin Synergizes with Histone Deacetylase and DNA Methyltransferase Inhibitors in Upregulating E-cadherin Expression Together with Inhibition of Migration and Invasion of Human Non-small Cell Lung Cancer Cells

  2013influential citation
• Diallyl Disulfide Increases Histone Acetylation and P21WAF1 Expression in Human Gastric Cancer Cells In vivo and In vitro

  2012cites this paper